David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$751M |
| 2 |
Advanced Micro Devices
AMD
|
+$751M |
| 3 |
Micron Technology
MU
|
+$426M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$363M |
| 5 |
ExxonMobil
XOM
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$546M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$485M |
| 3 |
VMW
VMware, Inc
VMW
|
+$393M |
| 4 |
Microsoft
MSFT
|
+$336M |
| 5 |
UnitedHealth
UNH
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.03% |
| 2 | Consumer Discretionary | 9.51% |
| 3 | Healthcare | 5.77% |
| 4 | Financials | 5.47% |
| 5 | Communication Services | 4.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZEUS
3151
DELISTED
Olympic Steel
ZEUS
| $777K | ﹤0.01% |
11,645
+663
| +6% | +$36.4K |
|
3152
Allient
ALNT
$1.58B
| $773K | ﹤0.01% |
25,602
+14,183
| +124% | +$400K |
|
3153
Advanced Energy
AEIS
$11B
| $771K | ﹤0.01% |
7,083
-45,383
| -86% | -$4.41M |
|
3154
CALL
CF Industries
CF
$19.3B
| $771K | ﹤0.01% |
9,700
+1,700
| +21% | +$135K |
|
3155
PUT
Cracker Barrel
CBRL
$1.3B
| $771K | ﹤0.01% |
10,000
| – | – |
|
3156
PMV Pharmaceuticals
PMVP
$69.5M
| $770K | ﹤0.01% |
248,505
+219,707
| +763% | +$581K |
|
3157
Design Therapeutics
DSGN
$981M
| $770K | ﹤0.01% |
290,628
+278,888
| +2,376% | +$639K |
|
3158
Biomea Fusion
BMEA
$125M
| $769K | ﹤0.01% |
+52,994
| New | +$644K |
|
3159
ZIM Integrated Shipping Services
ZIM
$3.38B
| $768K | ﹤0.01% |
77,805
-119,553
| -61% | -$1M |
|
3160
Greenlight Captial
GLRE
$505M
| $764K | ﹤0.01% |
66,928
+8,909
| +15% | +$99.1K |
|
3161
Envista
NVST
$4.41B
| $764K | ﹤0.01% |
+31,747
| New | +$759K |
|
3162
CALL
Trip.com Group
TCOM
$29B
| $763K | ﹤0.01% |
+21,200
| New | +$723K |
|
|
SIX
3163
DELISTED
Six Flags Entertainment Corp.
SIX
| $762K | ﹤0.01% |
30,367
-4,039
| -12% | -$93.1K |
|
|
FYBR
3164
PUT
DELISTED
Frontier Communications
FYBR
| $760K | ﹤0.01% |
30,000
| – | – |
|
3165
DXC Technology
DXC
$1.74B
| $759K | ﹤0.01% |
33,200
-337,789
| -91% | -$7.52M |
|
3166
State Street SPDR S&P Global Natural Resources ETF
GNR
$5.2B
| $759K | ﹤0.01% |
+13,401
| New | +$737K |
|
|
TSP
3167
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $757K | ﹤0.01% |
862,730
+106,817
| +14% | +$109K |
|
3168
Comscore
SCOR
$74.9M
| $757K | ﹤0.01% |
45,340
-7,851
| -15% | -$101K |
|
|
HCP
3169
PUT
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $756K | ﹤0.01% |
32,000
-11,900
| -27% | -$258K |
|
3170
Ally Financial
ALLY
$13B
| $755K | ﹤0.01% |
21,616
-129,837
| -86% | -$3.63M |
|
3171
James Hardie Industries
JHX
$17.6B
| $751K | ﹤0.01% |
19,526
-808
| -4% | -$24.3K |
|
3172
Stoke Therapeutics
STOK
$2.16B
| $751K | ﹤0.01% |
142,711
-62,455
| -30% | -$267K |
|
3173
CALL
TransAlta
TAC
$3.87B
| $748K | ﹤0.01% |
90,000
| – | – |
|
3174
ALX Oncology
ALXO
$277M
| $747K | ﹤0.01% |
50,178
+4,496
| +10% | +$42.7K |
|
3175
Champion Homes
SKY
$4.98B
| $746K | ﹤0.01% |
10,046
-28,867
| -74% | -$1.81M |
|
Similar funds
David Shaw's Q4 2023 Portfolio in Review
As of Q4 2023, David Shaw held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
- David Shaw added most to Netflix in Q4 2023, an estimated $751M increase.
- David Shaw's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
- David Shaw fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
- David Shaw's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
- David Shaw opened 575 new positions and closed 527 in Q4 2023.
- David Shaw's portfolio value rose 19% quarter-over-quarter to $114B.
Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.